Riluzole – March 2026

Oral suspension 50 mg per 10 mL, 300 mL

  • Brand names:
    • Teglutik®
  • Pharmaceutical Company:
    • ASTERI PHARMA PTY LTD
  • Condition/Indication: Amyotrophic lateral sclerosis
  • Meeting Date: March 2026
Public Summary Documents
Last updated
11 March 2026